-
Posted: December 24th, 2019, 3:00am GMT
Conditions: Thoracic Neoplasm; Chronic Pain Post-Procedural; Acute Post-thoracotomy Pain; Anesthesia, Local
Interventions: Drug: Levo-Bupivacaine Hydrochloride (HCl) 0.5 % in 20mL Injection; Drug: 0.9% Sodium Chloride 20mL Injection
Sponsors: Guy's and St Thomas' NHS Foundation Trust
Recruiting
-
Posted: December 23rd, 2019, 3:00am GMT
Conditions: Traumatic Brain Injury; Brain Inflammation; Cerebral Vasospasm
Interventions: Procedure: one site blockade of the stellate ganglion
Sponsors: University Medical Centre Ljubljana
Completed
-
Posted: December 13th, 2019, 3:00am GMT
Conditions: Anaplastic Astrocytoma, IDH-Wildtype; Glioblastoma, IDH-Wildtype; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Neoplasm in the Central Nervous System
Interventions: Procedure: Biospecimen Collection; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: EGFR/EGFRvIII Inhibitor WSD0922-FU; Procedure: Magnetic Resonance Imaging; Procedure: Therapeutic Conventional Surgery
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting
-
Posted: December 13th, 2019, 3:00am GMT
Conditions: Brain Metastases, Adult
Interventions: Diagnostic Test: CT and MRI Scans
Sponsors: University Health Network, Toronto
Recruiting
-
Posted: December 11th, 2019, 3:00am GMT
Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: Selpercatinib; Drug: Carboplatin; Drug: Cisplatin; Drug: Pemetrexed; Drug: Pembrolizumab
Sponsors: Loxo Oncology, Inc.; Eli Lilly and Company
Active, not recruiting
-
Posted: December 10th, 2019, 3:00am GMT
Conditions: Brain Metastases; Leptomeningeal Metastasis
Interventions: Drug: GDC-0084; Radiation: whole brain radiation therapy radiation
Sponsors: Memorial Sloan Kettering Cancer Center; Kazia Therapeutics
Active, not recruiting
-
Posted: December 9th, 2019, 3:00am GMT
Conditions: Advanced Solid Tumor; BRAF V600 Mutation
Interventions: Drug: ABM-1310; Drug: Cobimetinib
Sponsors: ABM Therapeutics Corporation
Active, not recruiting
-
Posted: December 6th, 2019, 3:00am GMT
Conditions: Intra Cerebral Hemorrhage; Subarachnoid Hemorrhage; Intraventricular Hemorrhage; Nontraumatic Haemorrhage
Sponsors: University of Maryland, Baltimore
Recruiting
-
Posted: December 5th, 2019, 3:00am GMT
Conditions: Melanoma; Non-small Cell Lung Carcinoma (NSCLC); Renal Cell Carcinoma (RCC); Small-cell Lung Cancer; Head and Neck Squamous Cell Cancer; Classical Hodgkin Lymphoma; Primary Mediastinal Large B-Cell Lymphoma; Urothelial Carcinoma; Microsatellite Instability-High Cancer; Gastric Cancer; Esophageal Cancer; Cervical Cancer; Hepatocellular Carcinoma; Merkel Cell Carcinoma; Brain Metastases, Adult
Interventions: Combination Product: LITT + Pembrolizumab
Sponsors: University of Florida; Monteris Medical
Terminated
-
Posted: December 5th, 2019, 3:00am GMT
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
Interventions: Drug: Fentanyl Citrate Buccal Tablet; Drug: Morphine; Other: Physical Performance Testing; Other: Placebo Administration; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: December 4th, 2019, 3:00am GMT
Conditions: Central Nervous System Tumor; Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma; Ependymoma; Medulloblastoma, Childhood; Germ Cell Tumor; Atypical Teratoid/Rhabdoid Tumor; Primitive Neuroectodermal Tumor; Choroid Plexus Carcinoma; Pineoblastoma, Childhood; Glioma
Interventions: Biological: SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
Sponsors: Seattle Children's Hospital
Recruiting